Results 211 to 220 of about 36,131 (273)

Intravitreal foscarnet is an effective adjunct after systemic therapy failure in pediatric antiviral-resistant cytomegalovirus retinitis. [PDF]

J Int Med Res
Amiri I, Shah P, Soleimani M, Zhang AY.
europepmc   +1 more source

Natamycin in Food and Ophthalmology: Knowledge Gaps and Emerging Insights from Zebrafish Models. [PDF]

Pharmaceuticals (Basel)
Bangeppagari M, Jagadish P, Srinivasa A, Choi W, Tiwari P.   +4 more
europepmc   +1 more source

Advancements and challenges in ophthalmic microneedles to treat eye diseases. [PDF]

Drug Deliv
Jo Y, Gouya C, Mieler WF, Kang-Mieler JJ.   +3 more
europepmc   +1 more source

From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeutics. [PDF]

Mater Today Bio
Sun M, Wang J, Fan W, Wang K, Wang Y, Zhang J, Ding S, Zhang C, Feng Z, Wang YG, Song Z, Tao Y.   +11 more
europepmc   +1 more source

Recent advances and future challenges in nanosystems for ocular drug delivery. [PDF]

J Pharmacol Exp Ther
Shahror RA, Fouda AY.
europepmc   +1 more source

Sustainable Solutions for Eye Drop Plastic Waste: Challenges, Innovations, and Environmental Impact. [PDF]

J Ophthalmol
Gandhi S, Balas M, Rai A.
europepmc   +1 more source

3D Bioprinting of Cellular Therapeutic Systems in Ophthalmology: from Bioengineered Tissue to Personalized Drug Delivery. [PDF]

Curr Ophthalmol Rep
Kim H, Ngo GH, Hong W, Lee SH, Mahajan VB, DeBoer C.   +5 more
europepmc   +1 more source

Next-generation smart ophthalmic biomaterials: From passive response to active interaction and closed-loop control. [PDF]

Bioact Mater
Zhang P, Nie Y, Wang X, Zhang X, Liu L.
europepmc   +1 more source

Therapeutic potential of curcumin in ophthalmic diseases: mechanisms and clinical applications. [PDF]

J Transl Med
Wang K, Tian T, Chen Z, He X, Xiang Y, Zuo G, Cheng S.   +6 more
europepmc   +1 more source